Advisor Group Holdings, Inc. Accelerate Diagnostics, Inc Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.54 - $1.41 $1,225 - $3,200	-2,270 Reduced 56.69%	1,734 $2,000
Q1 2022 May 04, 2022	BUY	$1.4 - $5.15 $5,605 - $20,620	4,004 New	4,004 $6,000
Q1 2021 May 13, 2021	SELL	$7.99 - $15.0 $71,910 - $135,000	-9,000 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$7.04 - $11.7 $3,520 - $5,850	-500 Reduced 5.26%	9,000 $68,000
Q3 2020 Nov 12, 2020	SELL	$9.98 - $18.04 $998 - $1,804	-100 Reduced 1.04%	9,500 $101,000
Q2 2020 Aug 14, 2020	BUY	$7.49 - $15.16 $3,745 - $7,580	500 Added 5.49%	9,600 $145,000
Q1 2020 May 18, 2020	BUY	$4.62 - $18.74 $42,042 - $170,534	9,100 New	9,100 $76,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $125M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.